Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Federal Trade Commission
McKinsey
Julphar
Argus Health
AstraZeneca
Queensland Health
Chubb
Medtronic
Cipla

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,584,305

« Back to Dashboard

Summary for Patent: 4,584,305
Title: Aiding the regression of neoplastic disease with 2,3,5,6-tetrahydro-6-phenylimidazo[2,1-b]thiazole
Abstract:Process of aiding regression and palliation of neoplastic disease in animal and human hosts comprising systemic administration to phenylimidazo[2,1-b]thiazole or a nontoxic acid addition salt thereof. Preferably the active ingredient is administered in a sufficient amount to provide dosages over the range from about 1 mg to about 5 mg/kg of body weight of the host.
Inventor(s): Brugmans; Josephus (Schilde-Antwerp, BE), Pollack; William (Belle Mead, NJ), Janssen; Paul A. J. (Vosselaar, BE), Tripodi; Daniel (Westford, MA)
Assignee: Janssen Pharmaceutica N.V. (Beerse, BE)
Application Number:06/230,578
Patent Claim Types:
see list of patent claims
Composition; Compound; Process; Use;

Drugs Protected by US Patent 4,584,305

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,584,305

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 5910573 ➤ Sign Up
Belgium 803718 ➤ Sign Up
Germany 2340632 ➤ Sign Up
France 2196172 ➤ Sign Up
Philippines 9277 ➤ Sign Up
South Africa 7305606 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
US Department of Justice
Queensland Health
Mallinckrodt
Daiichi Sankyo
Deloitte
Chinese Patent Office
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot